Chemoradiotherapy regimen for nasopharyngeal carcinoma

Chemoradiotherapy for nasopharyngeal carcinoma

Nasopharyngeal carcinoma is a relatively common cancer. The occurrence of this disease will pose a great threat to the patient's health and life. For the occurrence of the disease, the patient must have a good attitude to accept treatment, and also choose a regular hospital for treatment. The following is an introduction to the radiotherapy and chemotherapy regimen for nasopharyngeal carcinoma. Immunotherapy can treat the adverse reactions of chemotherapy, prevent the recurrence and metastasis of cancer cells, and improve the quality of life of nasopharyngeal carcinoma patients.

The main chemotherapy regimens for nasopharyngeal carcinoma are as follows:

What are the chemotherapy regimens for nasopharyngeal carcinoma? Combination chemotherapy regimens for nasopharyngeal carcinoma: CF regimen Cyclophosphamide and 5-fluorouracil are both broad-spectrum anticancer drugs and have certain therapeutic effects on nasopharyngeal carcinoma.

Can nasopharyngeal cancer cause high blood pressure?

Nasopharyngeal cancer generally does not cause high blood pressure, and the two diseases are not necessarily related. Nasopharyngeal cancer is a malignant tumor, and its main manifestations are blood in the aspirated sputum, nasal congestion, headache, neck mass, tinnitus and hearing loss. High blood pressure is generally caused by hypertension. Of course, if nasopharyngeal cancer causes panic and emotional tension, high blood pressure may occur.

Nasopharyngeal cancer may cause symptoms of abnormal blood pressure in patients. It is necessary to actively control blood pressure and actively treat rhinitis cancer. Generally, the best treatment method is radiotherapy, combined with traditional Chinese medicine treatment, and the use of Chinese herbal medicine for comprehensive treatment and comprehensive conditioning, which can effectively control the disease, reduce the patient's pain and control the tumor.

There is no direct link between nasopharyngeal cancer and increased blood pressure.